Department of Cardiovascular Sciences, European Hospital, Rome, Italy.
Department of Cardiology, Ca' Foncello Hospital, Treviso, Italy.
Eur J Heart Fail. 2015 Nov;17(11):1124-32. doi: 10.1002/ejhf.339. Epub 2015 Sep 4.
Despite advances in the management of patients with acute coronary syndrome (ACS), cardiogenic shock (CS) remains the leading cause of death in these patients. We describe the evolution of clinical characteristics, in-hospital management, and outcome of patients with CS complicating ACS.
We analysed data from five Italian nationwide prospective registries, conducted between 2001 and 2014, including consecutive patients with ACS. Out of 28 217 ACS patients enrolled, 1209 (4.3%) had CS: 526 (44%) at the time of admission and 683 (56%) later on during hospitalization. Over the years, a reduction in the incidence of CS was observed, even though this was not statistically significant (P for trend = 0.17). The proportions of CS patients with a history of heart failure declined, whereas the proportion of those with hypertension, renal dysfunction, previous PCI, and AF significantly increased. The use of PCI considerably increased from 2001 to 2014 [19% to 60%; percentage change 41, 95% confidence interval (CI) 29-51]. In-hospital mortality of CS patients decreased from 68% (95% CI 59-76) in 2001 to 38% (95% CI 29-47) in 2014 (percentage change -30, 95% CI -41 to -18). Compared with 2001, the risk of death was significantly lower in all of the registries, with reductions in adjusted mortality between 45% and 66%.
Over the last 14 years, substantial changes occurred in the clinical characteristics and management of patients with CS complicating ACS, with a greater use of PCI and a significant reduction in adjusted mortality rate.
尽管急性冠状动脉综合征(ACS)患者的治疗取得了进展,但心源性休克(CS)仍然是这些患者死亡的主要原因。我们描述了并发 ACS 的 CS 患者的临床特征、院内管理和结局的演变。
我们分析了 2001 年至 2014 年期间进行的五个意大利全国前瞻性注册研究的数据,这些研究纳入了连续的 ACS 患者。在 28217 例 ACS 患者中,有 1209 例(4.3%)并发 CS:526 例(44%)在入院时,683 例(56%)在住院期间。尽管趋势无统计学意义(P 趋势=0.17),但近年来 CS 的发生率有所下降。有心力衰竭史的 CS 患者比例下降,而有高血压、肾功能不全、既往 PCI 和 AF 的患者比例显著增加。PCI 的使用率从 2001 年到 2014 年显著增加[19%至 60%;百分比变化 41,95%置信区间(CI)29-51]。CS 患者的院内死亡率从 2001 年的 68%(95% CI 59-76)下降至 2014 年的 38%(95% CI 29-47)(百分比变化-30,95% CI -41 至 -18)。与 2001 年相比,所有登记处的死亡风险均显著降低,调整后的死亡率降低了 45%至 66%。
在过去的 14 年中,并发 ACS 的 CS 患者的临床特征和治疗方法发生了重大变化,PCI 的应用更加广泛,调整后的死亡率显著降低。